Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
52,300
+1,100 (2.15%)
At close: Feb 27, 2026
96.62%
Market Cap 2.00T
Revenue (ttm) 23.23B
Net Income (ttm) -13.14B
Shares Out 38.26M
EPS (ttm) -343.51
PE Ratio n/a
Forward PE 500.23
Dividend n/a
Ex-Dividend Date n/a
Volume 275,028
Average Volume 410,267
Open 49,900
Previous Close 51,200
Day's Range 49,600 - 53,000
52-Week Range 25,000 - 66,000
Beta 1.48
RSI 52.54
Earnings Date Mar 19, 2026

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.